back to top

Fevipiprant

New drug lowers risks of asthmatic attack, study shows

A NEW drug called Fevipiprant has a potential to lower asthmatic patients’ risks of suffering attack and being admitted...

Support the ICIR

We need your support to produce excellent journalism at all times.

- Advertisement

Recent